You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

MILRINONE LACTATE IN DEXTROSE 5% Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Milrinone Lactate In Dextrose 5%, and when can generic versions of Milrinone Lactate In Dextrose 5% launch?

Milrinone Lactate In Dextrose 5% is a drug marketed by Eugia Pharma, Woodward, B Braun, Baxter Hlthcare, Gland Pharma Ltd, Hikma, Hospira, and West-ward Pharms Int. and is included in nine NDAs.

The generic ingredient in MILRINONE LACTATE IN DEXTROSE 5% is milrinone lactate. There are nine drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the milrinone lactate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Milrinone Lactate In Dextrose 5%

A generic version of MILRINONE LACTATE IN DEXTROSE 5% was approved as milrinone lactate by FRESENIUS KABI USA on May 28th, 2002.

  Try a Trial

Summary for MILRINONE LACTATE IN DEXTROSE 5%
Drug patent expirations by year for MILRINONE LACTATE IN DEXTROSE 5%
Recent Clinical Trials for MILRINONE LACTATE IN DEXTROSE 5%

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shanghai Children's Medical CenterPhase 3
Ottawa Heart Institute Research CorporationPhase 4
Children's Hospital of PhiladelphiaN/A

See all MILRINONE LACTATE IN DEXTROSE 5% clinical trials

Pharmacology for MILRINONE LACTATE IN DEXTROSE 5%
Anatomical Therapeutic Chemical (ATC) Classes for MILRINONE LACTATE IN DEXTROSE 5%

US Patents and Regulatory Information for MILRINONE LACTATE IN DEXTROSE 5%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eugia Pharma MILRINONE LACTATE IN DEXTROSE 5% milrinone lactate INJECTABLE;INJECTION 209666-001 Sep 3, 2020 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Baxter Hlthcare MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 075834-002 May 28, 2002 AP RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
B Braun MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 076414-001 Aug 18, 2004 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hospira MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 075885-002 May 28, 2002 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.